Literature DB >> 11874876

Role of Th1 and Th2 cytokines in immune response to uncomplicated Plasmodium falciparum malaria.

Donato Torre1, Filippo Speranza, Massimo Giola, Alberto Matteelli, Roberto Tambini, Gilberto Biondi.   

Abstract

The relative balance between Th1 and Th2 cytokines appears crucial, since the role of cytokines has been evaluated in several studies by comparison of clinically heterogeneous groups of patients. The aim of this study is to determine the role of proinflammatory Th1 cytokines, interleukin-12 (IL-12) and gamma interferon (IFN-gamma), and anti-inflammatory Th2 cytokines, IL-4 and IL-10, in a homogeneous group of patients with uncomplicated Plasmodium falciparum malaria. Levels of IL-12, IFN-gamma, Il-4, and IL-10 in serum for 20 adult patients and 15 healthy control subjects were determined by an immunoenzymatic assay. Serum levels of Th1 cytokines, IL-12 (8.6 +/- 2.8 pg/ml; controls, 3.2 +/- 0.7 pg/ml) and IFN-gamma (39.2 +/- 67.6 pg/ml; controls, 8.4 +/- 6.3 pg/ml), were significantly increased at admission; 3 days later, levels of IL-12 in serum remained significantly high (8.8 +/- 2.6 pg/ml), whereas IFN-gamma levels returned to control values. The anti-inflammatory response of Th2 cytokines (IL-10 and IL-4) was distinct. Levels of IL-10 in serum were not significantly increased at day 0 and day 3 (306.6 +/- 200.4 pg/ml and 56.6 +/- 38.4 pg/ml, respectively; controls, 17.4 +/- 9.0 pg/ml). In contrast, levels of IL-4 in serum were not increased on admission (3.4 +/- 1.2 pg/ml; controls, 2.4 +/- 0.8 pg/ml), but at day 3 a moderate and significant increase of IL-4 levels was observed (4.5 +/- 1.7 pg/ml). In conclusion, the increase of Th1 cytokine IL-12 and IFN-gamma levels during the acute phase of uncomplicated P. falciparum malaria may reflect an early and effective immune response regulated by proinflammatory Th1 cytokines, and in particular IFN-gamma may play a role in limiting progression from uncomplicated malaria to severe and life-threatening complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874876      PMCID: PMC119927          DOI: 10.1128/cdli.9.2.348-351.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma.

Authors:  W Walker; M Aste-Amezaga; R A Kastelein; G Trinchieri; C A Hunter
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Interleukin 12 induction of interferon gamma-dependent protection against malaria.

Authors:  M Sedegah; F Finkelman; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

3.  Serum levels of interleukin-18 in patients with uncomplicated Plasmodium falciparum malaria.

Authors:  D Torre; M Giola; F Speranza; A Matteelli; C Basilico; G Biondi
Journal:  Eur Cytokine Netw       Date:  2001 Apr-Jun       Impact factor: 2.737

4.  Sterile protection of monkeys against malaria after administration of interleukin-12.

Authors:  S L Hoffman; J M Crutcher; S K Puri; A A Ansari; F Villinger; E D Franke; P P Singh; F Finkelman; M K Gately; G P Dutta; M Sedegah
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

5.  The role of TH1 and TH2 cells in a rodent malaria infection.

Authors:  A W Taylor-Robinson; R S Phillips; A Severn; S Moncada; F Y Liew
Journal:  Science       Date:  1993-06-25       Impact factor: 47.728

6.  Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice.

Authors:  M M Stevenson; M F Tam
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

7.  Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria.

Authors:  E M Riley; G Andersson; L N Otoo; S Jepsen; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

8.  In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice.

Authors:  P Jacobs; D Radzioch; M M Stevenson
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Interferon-gamma enhances the effect of antimalarial chemotherapy in murine Plasmodium vinckei malaria.

Authors:  P G Kremsner; S Neifer; S Schermuck; M F Chaves; K Sliwa; U Bienzle
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

10.  IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism.

Authors:  M M Stevenson; M F Tam; S F Wolf; A Sher
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

View more
  37 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children.

Authors:  Collins Ouma; Gregory C Davenport; Steven Garcia; Prakasha Kempaiah; Ateefa Chaudhary; Tom Were; Samuel B Anyona; Evans Raballah; Stephen N Konah; James B Hittner; John M Vulule; John M Ong'echa; Douglas J Perkins
Journal:  Hum Genet       Date:  2011-08-05       Impact factor: 4.132

3.  Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens.

Authors:  Ulysse Ateba-Ngoa; Sophie Jones; Jeannot Fréjus Zinsou; Josiane Honkpehedji; Ayola Akim Adegnika; Jean-Claude Dejon Agobe; Marguerite Massinga-Loembe; Benjamin Mordmüller; Teun Bousema; Maria Yazdanbakhsh
Journal:  Am J Trop Med Hyg       Date:  2016-06-06       Impact factor: 2.345

4.  TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models.

Authors:  Takahiro Tougan; Taiki Aoshi; Cevayir Coban; Yuko Katakai; Chieko Kai; Yasuhiro Yasutomi; Ken J Ishii; Toshihiro Horii
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

5.  Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria.

Authors:  Daniel O Ochiel; Gordon A Awandare; Christopher C Keller; James B Hittner; Peter G Kremsner; J Brice Weinberg; Douglas J Perkins
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 6.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

Review 7.  The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.

Authors:  K Artavanis-Tsakonas; J E Tongren; E M Riley
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.

Authors:  Elly O Munde; Winnie A Okeyo; Samwel B Anyona; Evans Raballah; Stephen Konah; Wilson Okumu; Lilian Ogonda; John Vulule; Collins Ouma
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

9.  Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria.

Authors:  Nnaemeka C Iriemenam; Christian M F Okafor; Halima A Balogun; Idowu Ayede; Yusuf Omosun; Jan-Olov Persson; Margareta Hagstedt; Chiaka I Anumudu; Roseangela I Nwuba; Marita Troye-Blomberg; Klavs Berzins
Journal:  Afr Health Sci       Date:  2009-06       Impact factor: 0.927

10.  Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.

Authors:  W Armand Guiguemde; Nicholas H Hunt; Jintao Guo; Annael Marciano; Richard K Haynes; Julie Clark; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.